Filter posts

We Need Your Input: BIO Survey on Effective FDA-Sponsor Communication

BIO is surveying members and non-members on their interactions with the FDA during the various …

New PhRMA Report: A Decade of Innovation in Rare Diseases

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in …

Getting Ready for #RDD2015 (Rare Disease Day 2015)

Rare Disease Day is just around the corner on February 28th. R&D investment into rare …

Biotech Could Miss a Multi-Billion Dollar Opportunity in Rare Disease

Drug development is expensive.  Drug development is risky.  Drug development takes a long time. The …

Op-Ed: As I Lay Dying

Former staff writer for the LA Times Laurie Becklund shares her experience ‘climbing ladders and …

World Rare Disease Day Celebrates Patient Advocacy and Activism Around The Globe

Global Genes™ and the identifiable Blue Denim Genes Ribbon™ provides opportunity to show support and …

FOX Business: BIO CEO Jim Greenwood Discusses Future of Medicine

BIO President and CEO Jim Greenwood appeared on Fox Business during the 17th Annual BIO …

Producing "21st Century Cures" - 2015 U.S. Legislative Outlook with Chairman Upton and Rep. DeGette

BIO President & CEO Jim Greenwood today sat down with Energy & Commerce Committee Chairman …

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …

Patients Remain the Focus for the Future of Personalizing Oncology

The 17th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria in New …